The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes

Diabetes Research and Clinical Practice

Volumn 93, Issue 2, 2011, Pages

  Orcajo, Beatriz ^a   Muruzabal, Francisco ^b   Isasmendi, María Concepción ^a   Gutierrez, Nerea ^a   Sánchez, Mikel ^c   Orive, Gorka ^b   Anitua, Eduardo ^b  

^a Clinica Juber   (Spain)

^b Instituto Eduardo Anitua   (Spain)

^c Unidad de Cirugia Artroscopica Mikel Sanchez   (Spain)

Author keywords

Diabetic foot ulcers; Mal perforant ulcer; Plasma rich in growth factors; Platelet rich plasma

Indexed keywords

FIBRIN; GROWTH FACTOR; TISSUE SCAFFOLD;

AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BONE INFECTION; CASE REPORT; DIABETIC FOOT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOOT AMPUTATION; FOOT EDEMA; HUMAN; INFECTION PREVENTION; INFECTION RISK; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; SKIN INCISION; SURGICAL DRAINAGE; THERAPY EFFECT; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; ULCER HEALING;

AGED; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC FOOT; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PLASMA; WOUND HEALING;

EID: 80051556513     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.04.008     Document Type: Article

References (17)

1. Grunfeld C. Diabetic foot ulcers: etiology, treatment, and prevention. Adv Intern Med 1992, 37:103-132.
2. Brod M. Quality of life issues in patients with diabetes and lower extremity ulcers: patients and care givers. Qual Life Res 1998, 7:365-372.
3. Reiber G.E., Boyko E.J., Smith D.G. Lower extremity foot ulcers and amputations in diabetes. Diabetes in America 1995, U.S. Government Printing Office, Washington, DC. M.I. Harris, C.C. Cowie, G. Reiber, E. Boyko, M. Stern, P. Bennett (Eds.).
4. Steed D.L., Attinger C., Colaizzi T., Crossland M., Franz M., Harkless L., et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 2006, 14:680-692.
5. Anitua E., Sanchez M., Orive G., Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007, 28:4551-4560.
6. Anitua E., Sánchez M., Nurden A.T., Nurden P., Orive G., Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006, 24:227-234.
7. Anitua E., Sánchez M., Orive G. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 2010, 62:741-752.
8. Blume P.A., Walters J., Payne W., Ayala J., Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008, 31:631-636.
9. Mutluoglu M., Uzun G., Yildiz S. Hyperbaric oxygen therapy in the treatment of diabetic foot ulcers - prudent or problematic: a case report. Ostomy Wound Manage 2010, 56:32-35.
10. Fernández-Montequín J.I., Valenzuela-Silva C.M., Díaz O.G., Savigne W., Sancho-Soutelo N., Rivero-Fernández F., et al. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J 2009, 6:432-443.
11. Steed D.L. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 2006, 117:143S-149S.
12. Fang R.C., Galiano R.D. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics 2008, 2:1-12.
13. Driver V.R., Hanft J., Fylling C.P., Beriou J.M. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006, 52:68-70.
14. Salemi S., Rinaldi C., Manna F., Guarneri G.F., Parodi P.C. Reconstruction of lower leg skin ulcer with autologous adipose tissue and platelet-rich plasma. J Plast Reconstr Aesthet Surg 2008, 61:1565-1567.
15. O'Connell S.M., Impeduglia T., Hessler K., Wang X.J., Carroll R.J., Dardik H. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers. Wound Repair Regen 2008, 16:749-756.
16. Villela D.L., Santos V.L. Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors 2010, 28:111-116.
17. Anitua E., Aguirre J.J., Algorta J., Ayerdi E., Cabezas A.I., Orive G., et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 2008, 84:415-421.